Microsplitting Ltd joins forces with EvaClean Europe to introduce its Infection Prevention System and FlashDry Absorbent Solutions to over 20...
WEST BLOOMFIELD TOWNSHIP, MI / ACCESSWIRE / October 31, 2024 / Cerebral Palsy Research Network, Hope for HIE and Newborn...
HONG KONG, Oct. 31, 2024 /PRNewswire/ -- In a groundbreaking initiative, The Hong Kong University of Science and Technology (HKUST)...
AI-powered clinical intelligence prioritizes patient outreach based on likelihood of successful intervention to improve patient health and reduce costly emergency...
Conference call and webcast to begin at 8:30 AM ETAUSTIN, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc....
Poster presentation at SITC to highlight extended follow-up data from AMPLIFY-7P Phase 1 study Oral presentation at SU2C Innovation Summit...
Late-breaking presentation highlights the pTau217 assay as an effective and efficient tool to screen participants for ALTITUDE-AD that reduces unnecessary...
BEIJING, Oct. 31, 2024 /PRNewswire/ -- When Yong Yong (pseudonym) navigates through the bustling exhibition hall, a soothing voice whisperers in...
Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PETImproves the efficiency of market entry with expertise...
EDMONTON, AB, Oct. 30, 2024 /CNW/ - Canadian startup Incluzia Inc. has won the 2024 AGE-WELL National Impact Challenge: Solutions for...
With nearly 1 billion people documented to have mental health problems, better strategies are needed to combat the global mental...
A Growing Community of Clinics Now Offer FDA-Cleared Evidence-Based Neurofeedback Treatment NEW YORK, Oct. 30, 2024 /PRNewswire/ -- GrayMatters Health (GMH),...
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the...
STOCKHOLM, SE / ACCESSWIRE / October 30, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...
GOTHENBURG, SWEDEN / ACCESSWIRE / October 30, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company...
BELLEVUE, Wash., Oct. 29, 2024 /PRNewswire/ -- 3X4 Genetics, a pioneer in functional nutrigenomics, is thrilled to announce the next step...
NEW YORK, Oct. 29, 2024 /PRNewswire/ -- QuantalX Neuroscience, a leader in objective neurodiagnostic technology, announces a significant discovery in the...
Topline data from the RewinD-LB Phase 2b study on track for December 2024 Detailed safety and efficacy data from RewinD-LB Phase...
BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
CHICAGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Pathos AI, a clinical-stage biotechnology company focused on re-engineering drug development through artificial...